Jeremy A. Ross

Statistics

Publications

Citations

229

H-Index

Active since

2015

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas at El Paso

Jeremy A. Ross is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and metastatic renal cell carcinoma therapy.

ORCID

Publications per year

2015–2023

Publications

Predicting survival in patients with advanced cancer in the last weeks of life: How accurate are prognostic models compared to clinicians’ estimates?

David Hui, Jeremy A. Ross, Minjeong Park et al. · Palliative Medicine · 2019 · 52 citations · Full text

Medicine, Oncology, Palliative Care +15

Medical Hematology/Oncology Fellows’ Perceptions of Online Medical Education During the COVID-19 Pandemic

Eric K. Singhi, Megan Dupuis, Jeremy A. Ross et al. · Journal of Cancer Education · 2020 · 39 citations · Full text

Medicine, Medical Education, Oncology +12

Lenvatinib with or Without Everolimus in Patients with Metastatic Renal Cell Carcinoma After Immune Checkpoint Inhibitors and Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapies

Andrew James Wiele, Tharakeswara Bathala, Andrew W. Hahn et al. · The Oncologist · 2021 · 36 citations · Full text

Medicine, Oncology, Pharmacology +17

Temsirolimus versus Pazopanib (TemPa) in Patients with Advanced Clear-cell Renal Cell Carcinoma and Poor-risk Features: A Randomized Phase II Trial

Nizar M. Tannir, Pavlos Msaouel, Jeremy A. Ross et al. · European Urology Oncology · 2019 · 20 citations · Full text

Medicine, Oncology, Pharmacotherapy +11

Transforming Mutations of Jak3 (A573V and M511I) Show Differential Sensitivity to Selective Jak3 Inhibitors

G. Steven Martinez, Jeremy A. Ross, Robert A. Kirken · Clinical Cancer Drugs · 2016 · 19 citations

Medicine, Oncology, Pharmacology +14

1–5 of 10